Author Information
Lanjuan Li is a prominent researcher affiliated with the State Key Laboratory and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases at The First Affiliated Hospital, College of Medicine, Zhejiang University, located in Hangzhou, China. Additionally, she holds a position in the Department of Chemistry at the University of Alberta in Edmonton, Canada. Her work is primarily focused on infectious diseases, where she has made significant contributions to understanding and treating various conditions.Research Contributions
Lanjuan Li's research encompasses a wide range of topics in infectious diseases and related fields. In recent years, her work has delved into the role of gut microbiota, liver injury, and cancer mechanisms. Notably, she has explored the therapeutic potential of Akkermansia muciniphila in liver injury, the efficacy of recombinant human interferon in inhibiting SARS-CoV-2, and the protective effects of mesenchymal stem cells against ferroptosis in acute liver injury. Her investigations into the modulation of gut microbiota and the mechanisms of cancer-related molecules like miR-650 and LncRNA PCGEM1 highlight her diverse research interests and contributions to advancing medical science.Aliases
Lanjuan Li is also known by several variations of her name, including Lan-juan Li, Lan Juan Li, and Lan–juan Li. These aliases might appear in different publications and databases.Publication and Citation Metrics
| Metric |
Value |
| Total Citations |
35,214 |
| h-index |
85 |
| Total Publications |
747 |
